Safety, tolerability, and pharmacokinetics of the broadly neutralizing human immunodeficiency virus (HIV)-1 monoclonal antibody VRC01 in HIV-exposed newborn infants

IMPAACT P1112 team

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, tolerability, and pharmacokinetics of the broadly neutralizing human immunodeficiency virus (HIV)-1 monoclonal antibody VRC01 in HIV-exposed newborn infants'. Together they form a unique fingerprint.

Medicine & Life Sciences